carbinoxamine maleate (Biocomp Pharma, Inc.)


Welcome to the PulseAid listing for the carbinoxamine maleate drug offered from Biocomp Pharma, Inc.. This Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Biocomp Pharma, Inc.
NON-PROPRIETARY NAME: carbinoxamine maleate
SUBSTANCE NAME: CARBINOXAMINE MALEATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2011-05-27
END MARKETING DATE: 0000-00-00


carbinoxamine maleate HUMAN PRESCRIPTION DRUG Details:

Item Descriptioncarbinoxamine maleate from Biocomp Pharma, Inc.
LABELER NAME: Biocomp Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 4(mg/1)
START MARKETING DATE: 2011-05-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44523-825_14266e97-674b-b6a9-37a2-a955f0a01c4f
PRODUCT NDC: 44523-825
APPLICATION NUMBER: ANDA090756

Other CARBINOXAMINE MALEATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avadel Pharmaceuticals (USA), Inc.Karbinal
Biocomp Pharma, Inc.carbinoxamine maleate
Boca Pharmacal, LLCCarbinoxamine Maleate
Breckenridge Pharmaceutical, Inc.Carbinoxamine Maleate
Carwin Pharmaceutical Associates, LLCRyVent
Mikart, Inc.carbinoxamine maleate